PHARMING GROUP Share Price Euronext Amsterdam
Stocks
NL0000377018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| Market Cap | 87Cr 99Cr 80Cr 74Cr 140.85Cr 9.44TCr 142.99Cr 956.46Cr 371.82Cr 4.64TCr 372.24Cr 364.24Cr 16TCr | P/E 2026 * |
39.9x | P/E 2027 * | 33.9x |
|---|---|---|---|---|---|
| Enterprise Value | 84Cr 96Cr 77Cr 72Cr 135.67Cr 9.09TCr 137.73Cr 921.28Cr 358.15Cr 4.47TCr 358.55Cr 350.85Cr 15TCr | EV / Sales 2026 * |
2.07x | EV / Sales 2027 * | 1.75x |
| Free-Float |
98.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PHARMING GROUP
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 04/03/2025 | |
Kenneth Lynard
DFI | Director of Finance/CFO | 58 | 01/10/2025 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Yanni
BRD | Director/Board Member | 71 | 11/12/2020 |
Mark Pykett
BRD | Director/Board Member | 62 | 11/12/2020 |
| Director/Board Member | 60 | 19/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.86% | +0.48% | +55.50% | +163.08% | 1,08200Cr | |
| +3.57% | +3.29% | +68.60% | +61.03% | 63TCr | |
| +3.99% | +3.05% | +37.93% | +93.37% | 46TCr | |
| +3.86% | +1.64% | +32.57% | +24.89% | 34TCr | |
| -0.56% | +0.96% | +41.67% | +39.35% | 30TCr | |
| -0.08% | +1.30% | +32.15% | +44.48% | 29TCr | |
| -1.54% | +2.81% | -25.35% | -39.61% | 22TCr | |
| +3.55% | +4.41% | +25.45% | +66.28% | 20TCr | |
| +4.21% | +2.65% | +17.47% | +71.11% | 16TCr | |
| Average | +2.10% | +4.58% | +31.78% | +58.22% | 41.03TCr | |
| Weighted average by Cap. | +2.25% | +5.53% | +42.31% | +83.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 40Cr 46Cr 37Cr 35Cr 66Cr 4.4TCr 67Cr 445.2Cr 173.07Cr 2.16TCr 173.26Cr 169.54Cr 7.44TCr | 45Cr 51Cr 41Cr 38Cr 73Cr 4.88TCr 74Cr 494.04Cr 192.06Cr 2.4TCr 192.27Cr 188.14Cr 8.26TCr |
| Net income | 4.3Cr 4.92Cr 3.95Cr 3.68Cr 6.98Cr 468.04Cr 7.09Cr 47Cr 18Cr 230.07Cr 18Cr 18Cr 792.8Cr | 3.96Cr 4.53Cr 3.64Cr 3.39Cr 6.43Cr 431.26Cr 6.53Cr 44Cr 17Cr 211.99Cr 17Cr 17Cr 730.49Cr |
| Net Debt | -3.19Cr -3.65Cr -2.93Cr -2.73Cr -5.18Cr -347.26Cr -5.26Cr -35Cr -14Cr -170.69Cr -14Cr -13Cr -588.2Cr | -8.51Cr -9.73Cr -7.82Cr -7.29Cr -14Cr -926.64Cr -14Cr -94Cr -36Cr -455.49Cr -37Cr -36Cr -1.57TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
